investor login

contact

team

dedicated funds

news

 portfolio

Cardiosense combines multimodal wearable sensors with AI to noninvasively detect early signs of cardiac disease and guide personalized therapy. Its FDA-cleared CardioTag device captures comprehensive physiological signals to monitor heart function and help clinicians identify and manage cardiac dysfunction sooner.

VISIT WEBSITE

 

 

HVP VII, Med Tech, Portfolio

back to portfolio

contact

© hatteras venture partners | all rights reserved | terms + privacy | site credit

 team

 portfolio

news

home

Hatteras Venture Partners is a venture capital firm that builds transformational companies in areas of health innovation.

dedicated funds

contact

 team

dedicated funds

news

home

 portfolio